Beyond Celiac hosted its 2nd Annual Celiac Disease Research Symposium, on Wednesday, October 10, 2018 at 6:00 PM. World renowned celiac disease experts joined us in Philadelphia to discuss the very latest in celiac disease research.
WATCH A RECORDING OF THE 2018 SYMPOSIUM
ABOUT THE 2ND ANNUAL RESEARCH SYMPOSIUM
Marie Robert, MD
Beyond Celiac CSO Marie Robert, MD is a nationally recognized gastrointestinal (GI) liver and pancreatic surgical pathologist with 25 years of experience in clinical diagnosis, teaching and collaborative scientific endeavors across a wide spectrum of diseases, including inflammatory and neoplastic conditions of the GI tract.
She is the lead author on the recently published Statement on Best Practices in the Use of Pathology as a Diagnostic Tool for Celiac Disease: A Guide for Clinicians and Pathologists in the American Journal of Surgical Pathology. She is also the senior investigator on a study of the pitfalls of testing biopsies in the evaluation of refractory celiac disease. Additional publications on celiac disease include the chapter on inflammatory conditions of the small intestine in the Odze, Goldblum and Crawford (eds) textbook “Surgical Pathology of the Gastrointestinal Tract, Liver, Biliary Tract and Pancreas,” considered the definitive text in GI surgical pathology worldwide. Currently, Dr. Robert leads a multinational study of more than 15 institutions on causes for and findings in repeat duodenal biopsies in celiac disease patients.
In addition to her post as the Beyond Celiac CSO, Dr. Robert is a Professor of Pathology and Medicine at Yale University School of Medicine. She is part of an international consortium of pathologists and gastroenterologists defining biopsy findings in early histologic stages of celiac disease (recent publication in Gut). She is a frequent invited speaker and educator on celiac disease nationally and internationally.
Ciaran Kelly, MD
Ciarán P Kelly, MD, is Professor of Medicine at Harvard Medical School and Director of Gastroenterology Training at Beth Israel Deaconess Medical Center. Dr. Kelly earned his medical degree from Trinity College in Dublin, Ireland where he was a Foundation Scholar and recipient of numerous academic awards. Dr Kelly has also received postgraduate clinical and research awards from the Crohn's and Colitis Foundation of America, the American Gastroenterological Association and the National Institutes of Health.
Dr. Kelly has engaged in patient care and research in celiac disease for more than 20 years. In 2004 he was a founder of the Celiac Center at BIDMC and continues to serve as its Medical Director. In 2013 he co-founded the Celiac Research Program at Harvard Medical School which brings together celiac disease researchers and educators from Harvard teaching hospitals.
Dr. Kelly is an internationally recognized expert in the diagnosis and management of celiac disease and, in his clinical practice, specializes in difficult-to-treat enteropathies. He also leads research programs on the pathogenesis of celiac disease, its diagnosis and new approaches to treatment. Dr. Kelly is the author of more than 250 clinical and basic research book chapters, invited reviews, and original research articles.
Maureen M. Leonard, MD, MMSc
Maureen Leonard, MD, MMSc, is the Clinical Director of the Center for Celiac Research and Treatment at MassGeneral Hospital for Children (MGHfC) and an Instructor of Pediatrics at Harvard Medical School (HMS). She sees adult and pediatric patients with celiac disease, non-celiac gluten sensitivity, dermatitis herpetiformis, gluten ataxia and other gluten-related disorders. Dr. Leonard obtained her medical degree from New York Medical College, completed her residency in general pediatrics at Tufts Medical Center and completed her fellowship in Pediatric Gastroenterology at MGHfC. An associate investigator at the Nutrition Obesity Research Center at HMS, Dr. Leonard received a Master’s Degree in Clinical and Translational Investigation from HMS.
Dr. Leonard’s research is focused on predicting and preventing celiac disease through precision medicine. Her current work includes identifying biomarkers that can predict intestinal healing in patients with celiac disease, building translational models capable of predicting autoimmune disease in high-risk individuals and working with Dr. Alessio Fasano on the NIH-funded Celiac Disease; Genomic, Environmental, Microbiome and Metabolomic Study (CDGEMM). Dr. Leonard currently holds funding from the Nutrition Obesity Research Center at Harvard and the NIH (FDK109620A).
Stephen D Miller, PhD
Stephen Miller, PhD is the Judy E. Gugenheim Research Professor of Microbiology-Immunology and Director of the Interdepartmental Immunobiology Center at Northwestern University Feinberg School of Medicine.
Dr. Miller is internationally recognized for his research on pathogenesis and regulation of autoimmune diseases. He has published over 400 journal articles, reviews and book chapters and has trained multiple generations of scientists. His work has significantly enhanced understanding of immune inflammatory processes underlying chronic autoimmune disease employing animal models of multiple sclerosis (MS), Type 1 diabetes (T1D) and celiac disease and treatment of established T cell-mediated autoimmune diseases using antigen-specific immune tolerance.
His current work is geared towards mechanistic understanding and clinical translation of the use of antigen-linked biodegradable PLG nanoparticles for the treatment of human immune-mediated diseases including autoimmunity, allergy and tissue/organ transplantation.